Sign in
Taking peopleNo phase

Calcium Replacement Therapy in Postoperative Hypoparathyroidism

Key facts

Who runs it
Tartu University Hospital
Where
Estonia2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
50 people, planned
Started
18 Nov 2025
Expected to end
Dec 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Calcium carbonate 1250 mg (500 mg elemental calcium) twice a day
  • Calcium carbonate 1250 mg (500 mg elemental calcium) 4 times a day
Record updated
11 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • patients over the age of 18 undergoing surgery involving both lobes of the thyroid gland (thyroidectomy, "near-total" thyroidectomy, subtotal thyroidectomy, and "completed" thyroidectomy)
  • Based on the first post-operative day analysis, PTH levels are below the normal range (in our hospitals 1.8-7.8 pmol/l), but not so low (below 1.06 pmol/L) as to require calcium replacement therapy with calcitriol (rocaltrol)

Who cannot take part

  • patients with concomitant hyperparathyroidism undergoing simultaneous thyroidectomy and parathyroidectomy for a parathyroid adenoma
  • previously diagnosed osteoporosis; the patient is already taking calcium and vitamin D supplements prior to thyroid surgery
  • renal insufficiency (eGFR < 30)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to evaluate whether a lower-dose calcium replacement therapy is non-inferior to a higher-dose regimen in preventing symptomatic hypoparathyroidism in patients following thyroidectomy. The hypothesis is:

Read full original descriptionShow less

• lower-dose calcium replacement therapy is non-inferior to higher-dose therapy in preventing symptomatic hypoparathyroidism during the first two postoperative weeks

Researchers will compare patients receiving a lower-dose calcium replacement regimen with those receiving a higher-dose regimen to assess whether the lower dose is not associated with a higher incidence of symptomatic hypoparathyroidism.

Patients who develop post-thyroidectomy hypoparathyroidism are divided into groups for calcium replacement therapy. If they are asymptomatic, they will be scheduled for a follow-up visit at two weeks after surgery. During the follow-up visit, calcium metabolism will be evaluated, and treatment adjusted if necessary.

The 2 groups in the trial

  • Lower dose calcium replacementExisting treatment, for comparison

    calcium carbonate 1250 mg x 2

    Treatment: Calcium carbonate 1250 mg (500 mg elemental calcium) twice a day

  • Higher dose calcium replacementExisting treatment, for comparison

    calcium carbonate 1250 mg x 4

    Treatment: Calcium carbonate 1250 mg (500 mg elemental calcium) 4 times a day

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Pilot Study of Calcium Replacement Therapy in Postoperative Hypoparathyroidism
Record updated
11 May 2026